Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry.
Avience Biomedicals Limited has expanded its product range from IVD rapid test kits to a comprehensive line of medical devices, including serology products and biochemistry analyzers. This demonstrates a commitment to diverse healthcare needs, focusing exclusively on the B2B and B2G markets.
The company’s products cater to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas.
In addition to manufacturing, the Company also act as distributors and traders of medical equipment.
The company’s manufacturing unit is situated in Noida, Uttar Pradesh.
The company offers a comprehensive range of diagnostic solutions, including:
As of January 31, 2026, the company had 75 permanent employees and 33 contractual employees
Competitive Strength
| Period Ended | 31 Jan 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 66.07 | 56.52 | 34.65 |
| Total Income | 41.94 | 45.97 | 24.37 |
| Profit After Tax | 5.74 | 7.23 | 2.14 |
| EBITDA | 10.34 | 11.41 | 4.08 |
| NET Worth | 28.52 | 22.78 | 6.21 |
| Reserves and Surplus | 24.49 | 18.75 | 2.93 |
| Total Borrowing | 26.73 | 22.16 | 15.13 |
| Amount in ₹ Crore | |||
| Company | Issue Type | Issue Size | Issue Price | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|
| Anthem Biosciences Ltd. | Mainboard | ₹3,395.00 Cr | ₹570 | ₹730.35 | +28.13% | ₹773.45 (-1.97%) |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh | 15.96 |
| 2 | Funding the working capital requirements of the Company | 8.25 |
| 3 | General Corporate Purposes | |
| Total | 24.21 |
| KPI | Jan 31, 206 | Mar 31, 2025 |
|---|---|---|
| ROE | 22.38% | 50.14% |
| ROCE | 16.99% | 24.84% |
| Debt/Equity | 0.94 | 0.97 |
| RoNW | 22.38% | 49.89% |
| PAT Margin | 15.86% | |
| EBITDA Margin | 24.70% | 25.22% |
| Price to Book Value | 2.94 | 3.68 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 17.94 | 12.56 |
| P/E (x) | 11.59 | 16.56 |
| IPO Date | 18 to 22 Jun, 2026 |
| Listing Date | Thu, Jun 25, 2026 |
| Face Value | ₹10 per share |
| Price Band | ₹196 to ₹208 |
| Lot Size | 600 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 14,53,800 shares (agg. up to ₹30 Cr) |
| Reserved for Market Maker | 82,200 shares (agg. up to ₹2 Cr) |
| Fresh Issue (Ex Market Maker) | 13,71,600 shares (agg. up to ₹29 Cr) |
| Net Offered to Public | 13,71,600 shares (agg. up to ₹29 Cr) |
| Share Holding Pre Issue | 40,31,256 shares |
| Share Holding Post Issue | 54,85,056 shares |
Mr. Dharam Deo Choudhary, Mr. Ram Nagina Choudhary, Mr. Janardan Pal and Ms. Deepa Choudhary.
| Share Holding Pre Issue | 87.89% |
| Share Holding Post Issue | 64.59% |
As per our analysis and Based on the information we have, this is the output.
Allah knows best.
If you find this result mistaken or questionable, let us know via email at info (@) halalstock.in
The IPO dashboard offers insights on the Latest Current & Upcoming IPOs in BSE & NSE. It also evaluates IPOs for Shariah compliance, ensuring alignment with Islamic principles for ethical investment choices.
Last Updated on June 17, 2026 Riyaasat Lifestyle IPO Incorporated in October 2021, Riyaasat Lifestyle Limited offers ethnic wear for Men and Women. The brand offers a collection of Kurta,
Last Updated on June 17, 2026 Avience Biomedicals Ltd. IPO Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic
Last Updated on June 16, 2026 Diksha Polymers Ltd. IPO Diksha Polymers is engaged in the manufacturing of PET bottles/containers, PET preforms, and caps. PET containers are primarily used for
You can contribute as little as
100, 200, 500 & so…
every bit counts.
